IL169828A0 - Albumin solution and method for the production thereof - Google Patents
Albumin solution and method for the production thereofInfo
- Publication number
- IL169828A0 IL169828A0 IL169828A IL16982805A IL169828A0 IL 169828 A0 IL169828 A0 IL 169828A0 IL 169828 A IL169828 A IL 169828A IL 16982805 A IL16982805 A IL 16982805A IL 169828 A0 IL169828 A0 IL 169828A0
- Authority
- IL
- Israel
- Prior art keywords
- albumin solution
- albumin
- groups
- virus
- reagents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/38—Albumins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a therapeutically usable virus-inactivated albumin and a method for producing a therapeutically usable virus-inactivated albumin, which is characterized by a combination of the following steps: (a) a first aqueous albumin solution is subjected to a virus inactivation treatment according to the SD method by contacting said aqueous albumin solution with SD reagents at a temperature of less than 45 DEG C; (b) the SD reagents are at least essentially removed by means of oil extraction and subsequent hydrophobic interaction chromatography, a hydrophobic matrix, especially a matrix to which optional hydrophobic groups can be bonded, being used for the chromatography process provided that said groups are aliphatic groups wherein C > 24, and a second albumin solution is obtained to which (c) one or several stabilizers from the group comprising sugar, amino acids, and sugar alcohols is/are optionally added provided that no indole stabilizer and no C6-C10 fatty acid are used as stabilizers; whereupon (d) the second albumin solution, to which stabilizer has been optionally added, is finished and sterilized by filtration and optionally filled into final containers.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AT2182003 | 2003-02-13 | ||
PCT/EP2004/001397 WO2004071524A1 (en) | 2003-02-13 | 2004-02-13 | Albumin solution and method for the production thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
IL169828A0 true IL169828A0 (en) | 2011-08-01 |
Family
ID=32854882
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL169828A IL169828A0 (en) | 2003-02-13 | 2005-07-21 | Albumin solution and method for the production thereof |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1592439B1 (en) |
JP (1) | JP2006517938A (en) |
KR (1) | KR20050103292A (en) |
CN (1) | CN100384471C (en) |
AT (1) | ATE362376T1 (en) |
AU (1) | AU2004212324B2 (en) |
BR (1) | BRPI0407458A (en) |
CA (1) | CA2514163A1 (en) |
CY (1) | CY1106793T1 (en) |
DE (1) | DE502004003834D1 (en) |
DK (1) | DK1592439T3 (en) |
ES (1) | ES2285427T3 (en) |
IL (1) | IL169828A0 (en) |
MX (1) | MXPA05008276A (en) |
NO (1) | NO20053677L (en) |
PL (1) | PL376644A1 (en) |
PT (1) | PT1592439E (en) |
RS (1) | RS50891B (en) |
RU (1) | RU2305556C2 (en) |
UA (1) | UA80469C2 (en) |
WO (1) | WO2004071524A1 (en) |
ZA (1) | ZA200506452B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102005023155A1 (en) * | 2005-05-13 | 2006-11-16 | Albutec Gmbh | albumin solution |
EP1966239A1 (en) * | 2005-12-22 | 2008-09-10 | CSL Behring GmbH | Octanoate-reduced human albumin |
ES2332846B1 (en) | 2007-10-26 | 2010-07-08 | Grifols, S.A. | USE OF THERAPEUTIC HUMAN ALBUMIN FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE TREATMENT OF PATIENTS AFFECTED BY COGNITIVE DISORDERS. |
ES2294976B1 (en) | 2007-11-12 | 2008-12-16 | Grifols, S.A. | "HIGH EFFECTIVE HUMAN ALBUMIN OBTAINING PROCEDURE FOR USE IN DETOXIFICATION THERAPY". |
EP2382993A1 (en) | 2010-04-19 | 2011-11-02 | KTB Tumorforschungsgesellschaft mbH | Combination of drugs with protein-binding prodrugs |
CN111195351A (en) * | 2020-01-20 | 2020-05-26 | 华兰生物工程重庆有限公司 | Preparation method of 5% low-concentration human serum albumin |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0669961B2 (en) * | 1984-09-25 | 1994-09-07 | 株式会社ミドリ十字 | Immunoglobulin heat treatment method |
US5094960A (en) * | 1988-10-07 | 1992-03-10 | New York Blood Center, Inc. | Removal of process chemicals from labile biological mixtures by hydrophobic interaction chromatography |
US5250662A (en) * | 1989-10-05 | 1993-10-05 | Alpha Therapeutic Corporation | Albumin purification |
DE19729778A1 (en) * | 1997-07-11 | 1999-01-21 | Blutspendedienst Der Drk Lande | Process for the preparation of virus-inactivated biological fluids |
US5919907A (en) * | 1997-12-22 | 1999-07-06 | Shanbrom Technologies Llc | Preparation and utilization of a novel sterile albumin |
IL136552A (en) * | 2000-06-05 | 2005-05-17 | Omrix Biopharmaceuticals Ltd | Method for the inactivation of viruses by a solvent - detergent combination and by nanofiltration |
-
2004
- 2004-02-13 DE DE502004003834T patent/DE502004003834D1/en not_active Expired - Lifetime
- 2004-02-13 CN CNB2004800038643A patent/CN100384471C/en not_active Expired - Fee Related
- 2004-02-13 AU AU2004212324A patent/AU2004212324B2/en not_active Ceased
- 2004-02-13 EP EP04710818A patent/EP1592439B1/en not_active Expired - Lifetime
- 2004-02-13 JP JP2006501841A patent/JP2006517938A/en active Pending
- 2004-02-13 UA UAA200508678A patent/UA80469C2/en unknown
- 2004-02-13 MX MXPA05008276A patent/MXPA05008276A/en active IP Right Grant
- 2004-02-13 RS YUP-2005/0624A patent/RS50891B/en unknown
- 2004-02-13 RU RU2005128507/15A patent/RU2305556C2/en not_active IP Right Cessation
- 2004-02-13 CA CA002514163A patent/CA2514163A1/en not_active Abandoned
- 2004-02-13 PT PT04710818T patent/PT1592439E/en unknown
- 2004-02-13 KR KR1020057014946A patent/KR20050103292A/en not_active Application Discontinuation
- 2004-02-13 WO PCT/EP2004/001397 patent/WO2004071524A1/en active IP Right Grant
- 2004-02-13 DK DK04710818T patent/DK1592439T3/en active
- 2004-02-13 PL PL376644A patent/PL376644A1/en unknown
- 2004-02-13 ES ES04710818T patent/ES2285427T3/en not_active Expired - Lifetime
- 2004-02-13 AT AT04710818T patent/ATE362376T1/en not_active IP Right Cessation
- 2004-02-13 BR BR0407458-0A patent/BRPI0407458A/en not_active IP Right Cessation
-
2005
- 2005-07-21 IL IL169828A patent/IL169828A0/en unknown
- 2005-07-29 NO NO20053677A patent/NO20053677L/en not_active Application Discontinuation
- 2005-08-12 ZA ZA200506452A patent/ZA200506452B/en unknown
-
2007
- 2007-08-07 CY CY20071101052T patent/CY1106793T1/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2285427T3 (en) | 2007-11-16 |
CN100384471C (en) | 2008-04-30 |
UA80469C2 (en) | 2007-09-25 |
RS50891B (en) | 2010-08-31 |
EP1592439B1 (en) | 2007-05-16 |
DE502004003834D1 (en) | 2007-06-28 |
DK1592439T3 (en) | 2007-09-10 |
NO20053677L (en) | 2005-10-31 |
ATE362376T1 (en) | 2007-06-15 |
CA2514163A1 (en) | 2004-08-26 |
KR20050103292A (en) | 2005-10-28 |
CN1798573A (en) | 2006-07-05 |
AU2004212324B2 (en) | 2009-05-07 |
RU2005128507A (en) | 2006-01-20 |
EP1592439A1 (en) | 2005-11-09 |
AU2004212324A1 (en) | 2004-08-26 |
ZA200506452B (en) | 2007-01-31 |
MXPA05008276A (en) | 2006-03-21 |
JP2006517938A (en) | 2006-08-03 |
WO2004071524A1 (en) | 2004-08-26 |
RS20050624A (en) | 2007-06-04 |
PT1592439E (en) | 2007-06-22 |
CY1106793T1 (en) | 2012-05-23 |
NO20053677D0 (en) | 2005-07-29 |
BRPI0407458A (en) | 2006-01-31 |
PL376644A1 (en) | 2006-01-09 |
RU2305556C2 (en) | 2007-09-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL169828A0 (en) | Albumin solution and method for the production thereof | |
EP0530173B1 (en) | Method for inactivating prions | |
DE60235810D1 (en) | METHOD OF PREPARING L-AMINO ACIDS BY ENTEROBACTERIACEAE STRAINS WITH INCREASED EXPRESSION OF THE FBA GENE | |
ATE240348T1 (en) | METHOD FOR PRODUCING A PROTEIN | |
MA32510B1 (en) | Process for the extraction of fatty acids from algal biomass | |
WO2003010176A3 (en) | Protein-nucleic acid complexes | |
IL95480A0 (en) | Process for the preparation of cyclic amino acids,and intermediates | |
ATE342316T1 (en) | METHOD FOR PRODUCING MICROBEADS THAT CONTAIN FAT SOLUBLE SUBSTANCES | |
DE502006006865D1 (en) | NEW DEHYDROGENASES, DERIVATIVES AND A METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE ALKANOLS | |
DE69906275T2 (en) | INTERMEDIATES AND METHOD FOR THE PRODUCTION OF OPTICALLY ACTIVE OCTANIC ACID DERIVATIVES | |
WO2004045540A3 (en) | Method for continuous, automated blending of solutions from acids and bases | |
DK1268399T3 (en) | Process for separating a basic amino acid from fermentation liquid | |
ATE221323T1 (en) | METHOD FOR PRODUCING A PROTEIN Isolate FROM A SUBSTANCE CONTAINING PROTEIN | |
WO2001081361A8 (en) | Compositions and method for diagnosing and treating conditions, disorders, or diseases involving cell death | |
BR0312530A (en) | Process of preparation of nitrophenol from nitrohalogenobenzene, nitrophenol, and, p-nitrophenol | |
KR101862332B1 (en) | Process for manufacturing influenza whole virus vaccine | |
ATE429447T1 (en) | PURIFICATION OF HER-2 VARIANTS | |
CN104098691A (en) | Metallothionein (MT) extraction and separation process for marine biological source efficient heavy metal removal agent | |
CN102690798A (en) | Method for extracting TAQ enzyme for amplification | |
ATE258181T1 (en) | METHOD FOR PRODUCING DISODIUM PAMIDRONATE | |
SU1085974A1 (en) | Process for preparing dl-glutamic acid | |
EP0238986A3 (en) | Process for the production of a preparation of blood coagulation factor viii in a concentrated form | |
CN1398638A (en) | Preparation of tick-borne encephalitis resisting vaccine | |
UA42436A (en) | method for producing the bovine serum albumin (BSA) | |
DE2339111B2 (en) | METHOD FOR PURIFYING PROTEINS AND OTHER BIOSPECIFICALLY ADSORBABLE SUBSTANCES |